Amazon (AMZN) Gets a Buy from Roth MKM
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Kulkarni is a 5-star analyst with an average return of 23.7% and a 62.28% success rate. Kulkarni covers the Communication Services sector, focusing on stocks such as Meta Platforms, Alphabet Class A, and Snap.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Amazon with a $243.32 average price target, which is a 10.74% upside from current levels. In a report released today, Truist Financial also maintained a Buy rating on the stock with a $250.00 price target.
The company has a one-year high of $242.52 and a one-year low of $151.61. Currently, Amazon has an average volume of 50.24M.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
22 minutes ago
- Globe and Mail
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028
Key Points Artificial intelligence (AI) has been Wall Street's most-followed trend since late 2022. In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track record of weighing down even the highest-flying companies. As Palantir stock comes back to Earth, three phenomenal businesses have the necessary catalysts to leapfrog it in the valuation department. Since late 2022, no investment trend has been hotter on Wall Street than the evolution of artificial intelligence (AI). Allowing AI-empowered software and systems to make split-second decisions and grow more efficient at their tasks over time is a game-changing technology that offers utility in most industries around the globe. In Sizing the Prize, the analysts at PwC pegged AI's worldwide addressable market at a whopping $15.7 trillion come 2030. Even if this estimate is only remotely in the ballpark, it would lead to a long list of companies benefiting from the rise of AI. Semiconductor giant Nvidia is often viewed as the face of the AI revolution. It's become the largest public company as a result of insatiable enterprise demand for its Hopper (H100) and successor Blackwell graphics processing units. But an argument can be made that AI-driven data-mining specialist Palantir Technologies (NASDAQ: PLTR) is now Wall Street's favorite AI stock. Since the start of 2023, shares of Palantir have soared by 1,940% and it's become one of the most-influential tech companies, with a market cap of more than $300 billion. But this doesn't mean other influential businesses won't surpass its valuation in the years to come Palantir's ascent to the top of the AI pedestal may be short-lived On one hand, Palantir does offer a sustainable moat. The company's Gotham and Foundry platforms aren't replicable at scale by any other companies, which means Palantir doesn't have to worry about having its clients stolen by other businesses. Further, Gotham is known for landing multiyear government contracts, and Foundry is an enterprise-based subscription model, which suggests the company's operating cash flow is highly predictable. However, Palantir is butting heads with historical headwinds that have a flawless track record of eventually weighing down even the most high-flying companies. For example, every next-big-thing trend for three decades, including the advent of the internet, has endured a bubble-bursting event early in its expansion. Investors frequently overestimate the early innings utility and adoption of game-changing technologies, and artificial intelligence likely isn't an exception. While Palantir's multiyear government contracts and subscriptions would buoy near-term sales, negative investor sentiment would likely weigh on its stock. The other issue for Palantir is its valuation. Whereas megacap companies on the leading edge of next-big-thing trends have historically topped out at price-to-sales (P/S) ratios of 30 to 43 over the last three decades, Palantir's P/S ratio is pushing above 104, as of this writing on July 1. This isn't sustainable and suggests that Palantir's market cap will plunge in the coming years. As Palantir stock (presumably) comes back to Earth, three magnificent growth and/or value stocks will have the opportunity to leapfrog it by 2028. Pfizer: current market cap of $142 billion The first amazing business that's only growing stronger and has all the tools necessary to become a more valuable company than Palantir over the next three years is pharmaceutical behemoth Pfizer (NYSE: PFE). What's odd about Pfizer stock recently hitting a 13-year low is that it's been punished for its own success. With combined sales of Pfizer's COVID-19 drugs plummeting from north of $56 billion in 2022 to $11 billion in 2024, recency bias has weighed down its shares. But if investors widen their lens and look at Pfizer's product portfolio since this decade began, it's a completely different story. When 2020 ended, Pfizer didn't have any sales from its COVID-19 franchise and full-year revenue came in at $41.9 billion. When 2024 came to a close, Pfizer had $11 billion in COVID-19 sales and $63.6 billion in product sales. That's 52% growth in net sales spanning just four years for a mature pharmaceutical company. Pfizer's oncology segment is a more specific reason its valuation can head higher. The $43 billion acquisition of cancer-drug developer Seagen in December 2023 vastly expands Pfizer's cancer-drug pipeline, as well as enhances its pricing power. Management has also previously pointed out that cost synergies from the combination will bolster the company's margins in the years following the deal. With the assumption that cancer screening tools continue to improve and access to medical care expands worldwide, Pfizer should have no trouble delivering for its patient shareholders over the next three years, if not well beyond. PayPal Holdings: current market cap of $73 billion Despite Palantir being worth more than four times as much as fintech giant PayPal Holdings (NASDAQ: PYPL), as of July 1, the latter offers a far more attractive risk-versus-reward profile over the coming three years. Even with competition in the digital payment space picking up, PayPal continues to be in the driver's seat for a technology that offers sustained double-digit growth potential. Developed and emerging markets shifting away from traditional cash payments to digital infrastructures affords PayPal and its peers a seemingly limitless ceiling. With few exceptions, PayPal's key performance indicators have been moving in the right direction since this decade began. Total payment volume (TPV) has surged from a reported $936 billion in 2020 to an annual run rate of $1.67 trillion, based on PayPal's first-quarter TPV. What's more, active customers are considerably more engaged, with the average number of payments over the trailing-12-month period climbing from 40.9 in 2020 to 59.4, as of the end of March 2025. This is a recipe for gross margin expansion. Innovation is another key puzzle piece for PayPal to eventually leapfrog Palantir in the valuation department. The potential to further monetize buy now, pay later solutions, as well as leverage AI to personalize its platforms for users, are just some of the ways innovation can reaccelerate PayPal's organic growth. The company's valuation also provides a launching point for its stock. Whereas Palantir is trading at a nosebleed P/S ratio of 104, PayPal has a forward price-to-earnings ratio of just 13, along with a storied history of blowing past its own conservative expectations. Intuitive Surgical: current market cap of $193 billion The third magnificent stock that can surpass Palantir's market cap by 2028 is robotic-assisted surgical systems developer Intuitive Surgical (NASDAQ: ISRG). The beauty of healthcare stocks (this includes Pfizer) is that they're highly defensive. Regardless of what's happening with the U.S. economy and stock market, people still come down with ailments and require medical care. Steady demand for everything from prescription medicine to medical devices and surgical procedures ensures that companies like Intuitive Surgical can deliver predictable growth year after year. On a more company-specific basis, Intuitive Surgical holds the lion's share of the robotic-assisted surgical market. Including the 367 da Vinci systems placed during the first quarter, it's now installed 10,189 systems since this century began. No other surgical device company is remotely close to this figure. What's more, buyers and lessees of da Vinci systems have typically invested a lot of surgical training time and money into these systems. In short, purchasers tend to remain clients for a very long time. But the best thing about Intuitive Surgical is, arguably, its revenue breakdown. Throughout the 2000s, selling its high-priced but mediocre-margin da Vinci surgical system accounted for the bulk of its revenue. Nowadays, selling instruments and accessories with each procedure, along with servicing its systems, accounts for a majority of full-year revenue. These are considerably higher margin categories, which has led to earnings growth (often) outpacing sales growth. Intuitive Surgical should see its market cap climb as the general use case of the da Vinci surgical system is expanded over time. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $692,914!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $963,866!* Now, it's worth noting Stock Advisor 's total average return is1,049% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Sean Williams has positions in PayPal and Pfizer. The Motley Fool has positions in and recommends Intuitive Surgical, Nvidia, Palantir Technologies, PayPal, and Pfizer. The Motley Fool recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy.
Globe and Mail
43 minutes ago
- Globe and Mail
Up Over 82% in 2025, Is It Too Late to Buy Roblox Stock?
Roblox (NYSE: RBLX) stock is soaring on the back of improving cash flow at the metaverse pioneer. *Stock prices used were the afternoon prices of July 1, 2025. The video was published on July 3, 2025. Should you invest $1,000 in Roblox right now? Before you buy stock in Roblox, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Roblox wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $692,914!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $963,866!* Now, it's worth noting Stock Advisor 's total average return is1,049% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Roblox. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
National Post
an hour ago
- National Post
J.D. Tuccille: NYC mayor hopeful's stated goal is 'seizing the means of production'
Article content In his formal response as a New York State Assemblyman to Hamas's bloody October 7 attack on Israel, Mamdani commented: 'the path toward a just and lasting peace can only begin by ending the occupation and dismantling apartheid.' He also frequently accuses Israel of engaging in ' genocide ' in its response to Hamas and refuses to condemn calls to 'globalize the intifada' which many view as targeting Jews outside Israel with attacks such as we've seen in Boulder, Montreal, and Washington, D.C. Article content In an analysis of voting data, Bloomberg found that — contrary to socialists' claims of representing the working class — Mamdani's votes were concentrated at the higher end of the income spectrum. He edged out Cuomo for the votes of those making more than $150 thousand per year and romped to victory among middle-class voters who earn between $50 thousand and $150 thousand per year. 'The former governor, however, outperformed Mamdani in low-income neighborhoods by a 13-point margin.' Article content Cost of living is a major concern for New York City residents, topping issues in polls. The wealthy can insulate themselves from the problem and the poor have programs that ease their burdens. That leaves middle-income voters — especially renters — as the most anxious in a pricey city. 'High costs of living are pushing middle-income families out of New York City,' commented the Bloomberg analysts. Article content That's true, but socialist math doesn't add up in any way that will lower the cost of living. A New York University Stern School of Business annual survey shows a net profit margin of 1.97 per cent for retail grocery stores. Mamdani's city-owned grocery stores aren't going to squeeze a lot of savings out of that — especially given the sad history of government-owned businesses, and especially grocery stores. Article content Mamdani doesn't help his case when he bases his proposal for funding the grocery scheme on a misreading of the city's books. Mamdani's plan assumes the city is subsidizing private grocery stores with $140 million that he wants to divert to socialist markets. But as the Washington Examiner's Timothy Carney points out, 'Mamdani is counting the $140 million in private spending as government spending.' Article content Mamdani's rent freeze also runs into math problems. New York City already limits rent increases for many units, and its famous bureaucracy puts barriers in the way of constructing more. A rent freeze would further reduce incentives to build housing — or even to maintain existing stock. Article content 'It's regulation on top of regulation, rather than addressing the root cause of housing undersupply and just making it easier to build housing of all types at all price points,' Emily Hamilton, director of the Urbanity Project at George Mason University's Mercatus Center, commented. Article content Mamdani also forgets that the wealthy people he wants to tax the hardest are the most mobile. Put the screws to them and they can choose to keep their money in Florida — already a popular destination. Article content But all of that is for New Yorkers to consider as they decide who to put in the mayor's office — and to confirm as the new face of the Democratic Party. A young-ish socialist who dislikes Israel and is iffy about his opinion of Jews in general is a dangerous bet in a country where socialism remains unpopular with the majority and most Americans are concerned about antisemitism. Article content
